Publikationen: Prof. Dr. rer. nat. A. Bozec
- Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosus. Ann Rheum Dis. 2026;85(1): 153-163
- Reply to Correspondence on: 'Effects of different B-cell-depleting strategies on the lymphatic tissue'. Ann Rheum Dis. 2026;85(1): e1-e2
- Loss of myeloperoxidase aggravates skin and joint inflammation in the mannan-induced psoriatic arthritis mouse model. J Leukoc Biol. 2025;117(9):
- Models of Rheumatoid Arthritis. Methods Mol Biol. 2025;2885(): 345-357
- BCMA T-Cell Engager Therapy in Patients with Refractory Autoimmune Disease. N Engl J Med. 2025;393(15): 1544-1547
- A multidimensional analysis of temporomandibular joint and ankle joint erosion in inflammatory arthritis. Front Immunol. 2025;16():
- DISTINCT MOLECULAR RESPONSES TO CD19 CAR-T CELL THERAPY VERSUS STANDARD PHARMACOTHERAPY IN SYSTEMIC LUPUS ERYTHEMATOSUS Ann Rheum Dis. 2025;84 Suppl 1(): 2177-2177
- SAFETY AND EFFICACY OFT CELL ENGAGER THERAPY IN PATIENTS WITH REFRACTORY AUTOIMMUNE DISEASE Ann Rheum Dis. 2025;84 Suppl 1():
- Degeneration and Impaired Resilience of Skull Bone and Hematopoietic Bone Marrow. bioRxiv. 2025;():
- SAFETY AND PRELIMINARY EFFICACY OF CD19 CAR T-CELL TREATMENT IN RHEUMATIC DISEASE-DATA FROM THE PHASE I/II CASTLE BASKET STUDY Ann Rheum Dis. 2025;84 Suppl 1():
- EFFECTS OF CAR-T CELL TREATMENT ON B CELL IMMUNITY IN SYSTEMIC AUTOIMMUNE DISEASES Ann Rheum Dis. 2025;83 Suppl 1():
- DISTINCT MOLECULAR PROFILES OF REMISSION POST-CD19 CAR-T CELL THERAPY VERSUS STANDARD IMMUNOSUPPRESSION IN SYSTEMIC LUPUS ERYTHEMATOSUS J Rheumatol. 2025;52 Suppl 1(): 8-8
- Effects of different B-cell-depleting strategies on the lymphatic tissue. Ann Rheum Dis. 2025;84(12): 2065-2074
- Advancing oral immunology for improving oral health. J Orofac Orthop. 2025;86(1): 33-37
- CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series. Lancet Rheumatol.. 2025;7(2): e83-e93
- Metabolic rewiring controlled by HIF-1α tunes IgA-producing B-cell differentiation and intestinal inflammation. Cell Mol Immunol. 2025;22(1): 54-67
- Mutual Amplification of GLI2/Hedgehog and Transcription Factor JUN/AP-1 Signaling in Fibroblasts in Systemic Sclerosis: Potential Implications for Combined Therapies. Arthritis Rheumatol. 2025;77(1): 92-98
- Correction to CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2025;77(3):
- Melanoma bone metastasis-induced osteocyte ferroptosis via the HIF1α-HMOX1 axis. Bone Res. 2025;13(1):
- CD19 Chimeric Antigen Receptor T Cell Treatment: Unraveling the Role of B Cells in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2024;76(4): 497-504
- L-arginine metabolism inhibits arthritis and inflammatory bone loss. Ann Rheum Dis. 2024;83(1): 72-87
- Eosinophils preserve bone homeostasis by inhibiting excessive osteoclast formation and activity via eosinophil peroxidase. Nat Commun. 2024;15(1):
- Acod1-mediated inhibition of aerobic glycolysis suppresses osteoclast differentiation and attenuates bone erosion in arthritis. Ann Rheum Dis. 2024;83(12): 1691-1706
- BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease. N Engl J Med. 2024;391(9): 867-869
- Selective CAR T cell-mediated B cell depletion suppresses IFN signature in SLE. JCI Insight. 2024;9(12):
- Expression of HIF1α in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery. Ann Rheum Dis. 2024;83(8): 984-997
- Osteocytes support bone metastasis of melanoma cells by CXCL5. Cancer Lett. 2024;590():
- Bispecific T cell engager therapy for refractory rheumatoid arthritis. Nat Med. 2024;30(6): 1593-1601
- CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up. N Engl J Med. 2024;390(8): 687-700
- Inhibition of aerobic glycolysis viaAcod1 suppresses osteoclast differentiation and reduces bone erosion in arthritis J Bone Miner Res. 2024;39 Suppl 1(): 219-219
- CD19-CAR T-cell therapy induces deep tissue depletion of B cells. Ann Rheum Dis. 2024;():
- Safety and Preliminary Efficacy of CD19 CAR-T Cell Treatment in Rheumatic Disease - Data from the First Part of the Phase I/II CASTLE Basket Study Arthritis Rheumatol. 2024;76 Suppl 9(): 3573-3574
- Deep B Cell Tissue Depletion Following Anti-CD19 CART Cells Therapy Arthritis Rheumatol. 2024;76 Suppl 9(): 1629-1631
- Eosinophil peroxidase induces a pro-resolving phenotype in macrophages Eur J Immunol. 2024;54 Suppl 1(): 87-87
- Serum Proteomic Analysis Identifies Markers Associated with Anti-CD19 CAR T Therapeutic Response in Autoimmune Diseases Mol Ther. 2024;32 Suppl 1(4): 849-850
- Selective CAR-T cell mediated B cell depletion suppresses interferon signature in systemic lupus erythematosus Eur J Immunol. 2024;54 Suppl 1(): 1519-1519
- Comprehensive Immune Profiling of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy in Patients with Autoimmune Disease Arthritis Rheumatol. 2024;76 Suppl 9(): 1623-1626
- Safety of Bispecific T-cell Engager Therapy in Autoimmune Disease Arthritis Rheumatol. 2024;76 Suppl 9(): 2299-2300
- BCMA-targeted Bispecific T Cell-engager Therapy of Autoimmune Disease Arthritis Rheumatol. 2024;76 Suppl 9(): 5403-5405
- BITEING MULTI-DRUG RESISTANT RHEUMATOID ARTHRITIS WITH CD19-T CELL ENGAGERS Ann Rheum Dis. 2024;83 Suppl 1():
- LONG-TERM SAFETY AND EFFICACY OF CAR-T CELL TREATMENT IN SEVERE AND TREATMENT REFRACTORY AUTOIMMUNE DISEASE Ann Rheum Dis. 2024;83 Suppl 1():
- SAFETY AND PRELIMINARY EFFICACY OF CD19 CAR-T CELL TREATMENT IN RHEUMATIC DISEASE-DATA FROM THE FIRST PART OFTHE PHASE I/II CASTLE BASKET STUDY Ann Rheum Dis. 2024;83 Suppl 1():
- Chronic Systemic Infection of Mice with Leishmania infantum Leads to Increased Bone Mass. J Bone Miner Res. 2023;38(1): 86-102
- Macrophages inhibit Coxiella burnetii by the ACOD1-itaconate pathway for containment of Q fever. EMBO Mol Med. 2023;15(2):
- High-fat-diet-associated intestinal microbiota exacerbates psoriasis-like inflammation by enhancing systemic γδ T cell IL-17 production. Cell Rep. 2023;42(7):
- Four-and-a-Half LIM-Domain Protein 2 (FHL2) Induces Neuropeptide Y (NPY) in Macrophages in Visceral Adipose Tissue and Promotes Diet-Induced Obesity. Int J Mol Sci. 2023;24(19):
- Eosinophils counteract osteoclast-mediated bone degradation via the secretion of eosinophil peroxidase J Bone Miner Res. 2023;38 Suppl 2(): 273-273
- Aging of the bone marrow niche awakens dormant breast cancer cells and promotes overt bone metastasis J Bone Miner Res. 2023;38 Suppl 2(): 115-115
- Alteration of Gut Microbiota in Individuals at High-Risk for Rheumatoid Arthritis Associated With Disturbed Metabolome and the Initiation of Arthritis Through the Triggering of Mucosal Immunity Imbalance. Arthritis Rheumatol. 2023;75(10): 1736-1748
- A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigens. Nanomedicine. 2023;48():
- Adult alcohol drinking and emotional tone are mediated by neutral sphingomyelinase during development in males. Cereb Cortex. 2023;33(3): 844-864
- Epigenetic basis of oncogenic-Kras-mediated epithelial-cellular proliferation and plasticity. Dev Cell. 2022;57(3): 310-328.e9
- Mitochondrial respiration in B lymphocytes is essential for humoral immunity by controlling the flux of the TCA cycle. Cell Rep. 2022;39(10):
- Anti-inflammatory, but not osteoprotective, effect of the TRAF6/CD40 inhibitor 6877002 in rodent models of local and systemic osteolysis. Biochem Pharmacol. 2022;195():
- Epithelial HIF2α expression induces intestinal barrier dysfunction and exacerbation of arthritis. Ann Rheum Dis. 2022;81(8): 1119-1130
- The soluble CD83 protein prevents bone destruction by inhibiting the formation of osteoclasts and inducing resolution of inflammation in arthritis. Front Immunol. 2022;13():
- Rheumatoid arthritis and osteoimmunology: The adverse impact of a deregulated immune system on bone metabolism. Bone. 2022;162():
- Estrogen-mediated downregulation of HIF-1α signaling in B lymphocytes influences postmenopausal bone loss. Bone Res. 2022;10(1):
- Inflammatory activation of the FcγR and IFNγR pathways co-influences the differentiation and activity of osteoclasts. Front Immunol. 2022;13():
- Non-Invasive Characterization of Experimental Bone Metastasis in Obesity Using Multiparametric MRI and PET/CT. Cancers (Basel). 2022;14(10):
- Distinct Metabolism of Bone Marrow Adipocytes and their Role in Bone Metastasis. Front Endocrinol (Lausanne). 2022;13():
- Hypoxia-immune-related microenvironment prognostic signature for osteosarcoma. Front Cell Dev Biol. 2022;10():
- Age-associated B cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-α-mediated ERK1/2 and JAK-STAT1 pathways. Ann Rheum Dis. 2022;81(11): 1504-1514
- Hypoxia Promotes Neutrophil Survival After Acute Myocardial Infarction. Front Immunol. 2022;13():
- Murine Metatarsus Bone and Joint Collagen-I Fiber Morphologies and Networks Studied With SHG Multiphoton Imaging. Front Bioeng Biotechnol. 2021;9():
- Systemic PPARγ Antagonism Reduces Metastatic Tumor Progression in Adipocyte-Rich Bone in Excess Weight Male Rodents. J Bone Miner Res. 2021;36(12): 2440-2452
- The Transcription Factor FRA-1/AP-1 Controls Lipocalin-2 Expression and Inflammation in Sepsis Model. Front Immunol. 2021;12():
- X-linked inhibitor of apoptosis protein (XIAP) inhibition in systemic sclerosis (SSc). Ann Rheum Dis. 2021;80(8): 1048-1056
- Apremilast inhibits inflammatory osteoclastogenesis. Rheumatology (Oxford). 2021;61(1): 452-461
- Systemic versus local adipokine expression differs in a combined obesity and osteoarthritis mouse model. Sci Rep. 2021;11(1):
- Novel approaches to target the microenvironment of bone metastasis. Nat Rev Clin Oncol. 2021;18(8): 488-505
- Hypoxia-Inducible Factors Regulate Osteoclasts in Health and Disease. Front Cell Dev Biol. 2021;9():
- Neutral sphingomyelinase mediates the co-morbidity trias of alcohol abuse, major depression and bone defects. Mol Psychiatry. 2021;26(12): 7403-7416
- The Special Developmental Biology of Craniofacial Tissues Enables the Understanding of Oral and Maxillofacial Physiology and Diseases. Int J Mol Sci. 2021;22(3):
- Fra-2/AP-1 regulates melanoma cell metastasis by downregulating Fam212b. Cell Death Differ. 2021;28(4): 1364-1378
- Regulatory eosinophils induce the resolution of experimental arthritis and appear in remission state of human rheumatoid arthritis. Ann Rheum Dis. 2021;80(4): 451-468
- Morphological, functional, and molecular assessment of breast cancer bone metastases by experimental ultrasound techniques compared with magnetic resonance imaging and histological analysis. Bone. 2021;144():
- Changes in mechanical loading affect arthritis-induced bone loss in mice Bone. 2020;131():
- Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients. Front Oncol. 2020;10():
- Osteocyte necrosis triggers osteoclast-mediated bone loss through macrophage-inducible C-type lectin. J Clin Invest. 2020;130(9): 4811-4830
- COMPARISON OF INFLAMMATION DURING METABOLIC CHANGES IN RHEUMATOID AND OSTEOARTHRITIS MOUSE MODELS Ann Rheum Dis. 2020;79 Suppl 1(): 242-243
- ALLERGIC ASTHMA INDUCES THE ACCUMULATION OF SYNOVIAL RESIDENT EOSINOPHILS, TRIGGERING THE RESOLUTION OF INFLAMMATORY ARTHRITIS Ann Rheum Dis. 2020;79 Suppl 1(): 86-86
- L-ARGININE SUPPLEMENTATION AMELIORATES BONE EROSION IN RHEUMATOID ARTHRITIS THROUGH INHIBITION OF RANKL/RANK/TRAF6 PATHWAY AND REPROGRAMMING OSTEOCLAST METABOLISM Ann Rheum Dis. 2020;79 Suppl 1(): 927-927
- Defining Metaniches in the Oral Cavity According to Their Microbial Composition and Cytokine Profile. Int J Mol Sci. 2020;21(21):
- Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model. J Vis Exp. 2020;(162):
- A Human Periodontal Ligament Fibroblast Cell Line as a New Model to Study Periodontal Stress. Int J Mol Sci. 2020;21(21):
- Development and Exploitation of a Fully Human and Modular Organotypic Bone Marrow Niche Model to Study the Role of Stroma-Produced Factors in Human MDS Blood. 2020;136 Suppl 1():
- Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis. Nat Rev Rheumatol. 2019;15(1): 9-17
- Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases. FASEB J. 2019;33(1): 1401-1414
- Binding Immunoglobulin Protein (BIP) Inhibits TNF-α-Induced Osteoclast Differentiation and Systemic Bone Loss in an Erosive Arthritis Model. ACR Open Rheumatol. 2019;1(6): 382-393
- Fra1 Controls Rheumatoid Factor Autoantibody Production by Bone Marrow Plasma Cells and the Development of Autoimmune Bone Loss. J Bone Miner Res. 2019;34(7): 1352-1365
- In Vivo Models of Rheumatoid Arthritis. Methods Mol Biol. 2019;1914(): 269-280
- Soluble CD83 Triggers Resolution of Arthritis and Sustained Inflammation Control in IDO Dependent Manner. Front Immunol. 2019;10():
- Prediction of early metastatic disease in experimental breast cancer bone metastasis by combining PET/CT and MRI parameters to a Model-Averaged Neural Network. Bone. 2019;120(): 254-261
- Osteoprotective action of low-salt diet requires myeloid cell-derived NFAT5. JCI Insight. 2019;4(23):
- Transcription factor Fra-1 targets arginase-1 to enhance macrophage-mediated inflammation in arthritis. J Clin Invest. 2019;129(7): 2669-2684
- Adipocytokines and Obesity in the Context of Rheumatoid and Osteoarthritis Mouse Models Arthritis Rheumatol. 2019;71():
- EFFECT OF HIGH FAT DIET ON SYSTEMIC AND LOCAL INFLAMMATION IN THE CONTEXT OF OSTEOARTHRITIS AND RHEUMATOID ARTHRITIS MOUSE MODELS Ann Rheum Dis. 2019;78(): A72-A72
- How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis Front Immunol. 2019;10():
- Obesity as an Influence Parameter of rheumatoid Arthritis and Osteoarthritis (Arthrosis) in the Mouse Model Internist (Berl). 2019;60(): S39-S39


